144P Association between immune-related adverse events and survival in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
Autor: | Hayase, T., Washino, S., Shirotake, S., Inoue, M., Kagawa, M., Takeshita, H., Miura, Y., Hyodo, Y., Izumi, K., Kawakami, S., Saito, K., Kageyama, Y., Oyama, M., Miyagawa, T. |
---|---|
Zdroj: | In Annals of Oncology November 2022 33 Supplement 9:S1488-S1489 |
Databáze: | ScienceDirect |
Externí odkaz: |